All State & Fed.
JX
§
Why Casetext
Pricing
Help
Sign In
Back to
Results
Sepracor Inc. v. Dey LP et al
REPLY BRIEF re MOTION to Consolidate Cases
Read
Read
Cited Authorities
Cited Authorities
4
4
Cited authorities
Aventis Pharma Deutschland v. Cobalt Pharmaceuts
355 F. Supp. 2d 586 (D. Mass. 2005)
Cited 14 times
Holding no inducement where proposed labeling did not include instructions for infringing uses
Section 355 - New drugs
21 U.S.C. § 355
Cited 2,252 times
340 Legal Analyses
Granting the court discretion to change the date on which an ANDA may be approved if "either party to the action failed to reasonably cooperate in expediting the action"
Section 253 - Disclaimer
35 U.S.C. § 253
Cited 180 times
37 Legal Analyses
Granting patentee authority to disclaim issued or pending claims
Section 1.321 - Statutory disclaimers, including terminal disclaimers
37 C.F.R. § 1.321
Cited 75 times
32 Legal Analyses
Incorporating the language of § 253